课题基金 / 基金详情

Chemical Genetics of a C. elegans Signaling Cascade

Chemical Genetics of a C. elegans Signaling Cascade
线虫信号级联的化学遗传学
批准号:
6443653
负责人:
ANN E SLUDER
金额:
$9.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-05-01 至 2003-04-30

项目摘要

项目成果

ANN E SLUDER的其他基金

相似基金

相关文献

中文摘要
翻译
化学遗传学是研究基因功能的传统遗传学和生物化学策略的替代方法。化学遗传学允许不服从传统遗传方法的筛选策略,从而促进生物途径的新组分的发现。与特定蛋白质结合的小分子化合物可以像基因突变一样抑制或激活该蛋白质的功能。与大多数基因突变相反,生物活性小分子本质上是有条件的。此外,化学遗传学可以识别生物途径中的化学干预点和针对这些靶点的潜在药物线索。本提案中描述的实验将测试化学遗传策略,用于识别参与三种信号传导途径(TGF-β,环核苷酸和胰岛素信号传导)的基因,这些信号传导途径参与秀丽隐杆线虫幼虫发育期间生长和滞育(dauer)之间的转换。本研究的具体目标是:1)建立一种灵敏、高通量的自动化检测方法。elegans dauer恢复和2)使用1400种FDA批准的化合物进行中试筛选。长期目标是确定一组生物活性化合物及其进入C. elegans,并开发针对涉及人类疾病的同源靶标的治疗剂。拟议的商业应用:针对TGF-β、环核苷酸和胰岛素信号传导途径的组分的生物活性化合物可被开发为人类疾病治疗剂。梭本文所述的基于秀丽隐杆线虫的化学遗传学方法可以被遗传修饰以鉴定对其它疾病基因途径特异的化合物,对于所述其它疾病基因途径存在C.线虫同源物。
英文摘要
Chemical genetics is an alternative to traditional genetic and biochemical strategies for studying in gene function. Chemical genetics permits screening strategies not amenable to traditional genetic methods, thereby facilitating discovery of new components of biological pathways. Small molecule compounds that bind to a specific protein can, like genetic mutations, either inhibit or activate the function of that protein. In contrast to most genetic mutations, bioactive small molecules are intrinsically conditional. In addition, chemical genetics can identify chemical intervention points within biological pathways and potential drug leads specific to these targets. The experiments described in this proposal will test a chemical genetic strategy for identifying genes involved in the three signaling pathways, TGF-beta, cyclic nucleotide, and insulin signaling, involved in the switch between growth and diapause (dauer) during Caenorhabditis elegans larval development. The specific aims of this proposal are: 1) to develop a sensitive high- throughput automated assay to measure C. elegans dauer recovery and 2) to perform a pilot screen using 1400 FDA-approved compounds. The long-term goals are to identify a collection of bioactive compounds and their molecular entry points into the TGF-beta, cyclic nucleotide, and insulin-signaling pathways in C. elegans, and to develop therapeutics against homologous targets involved in human disease. PROPOSED COMMERCIAL APPLICATIONS: Bioactive compounds directed against components of the TGF-beta, cyclic nucleotide, and insulin signaling pathways can be developed as human disease therapeutics. The C. elegans-based chemical genetic approach described herein can be genetically modified to identify compounds specific for other disease gene pathways for which there are C. elegans homologs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RILUZOLE MOA: TARGETS FOR IMPROVED NEUROPROTECTIVE DRUGS
  • 批准号:
    6882749
  • 项目类别:
  • 资助金额:
    $25.38万
  • 财政年份:
    2004
  • 负责人:
    ANN E SLUDER
  • 依托单位:
DEVELOPMENT OF NUCLEAR RECEPTORS AS ANTHELMINTIC TARGETS
  • 批准号:
    6292026
  • 项目类别:
  • 资助金额:
    $7.62万
  • 财政年份:
    2001
  • 负责人:
    ANN E SLUDER
  • 依托单位:
Development of nuclear receptors as anthelmintic targets
  • 批准号:
    6626052
  • 项目类别:
  • 资助金额:
    $32.21万
  • 财政年份:
    2001
  • 负责人:
    ANN E SLUDER
  • 依托单位:
Development of nuclear receptors as anthelmintic targets
  • 批准号:
    6485433
  • 项目类别:
  • 资助金额:
    $42.43万
  • 财政年份:
    2001
  • 负责人:
    ANN E SLUDER
  • 依托单位:
海外基金